Split high-dose oral levothyroxine treatment as a successful therapy option in myxedema coma
- PMID: 29026577
- PMCID: PMC5628197
- DOI: 10.1002/ccr3.1131
Split high-dose oral levothyroxine treatment as a successful therapy option in myxedema coma
Abstract
High-dose intravenous thyroxine (T4) is the preferable treatment for myxedema coma. We describe the clinical course of a 69-year-old man who presented with myxedema coma and received oral levothyroxine (LT4) therapy (1 mg) in a split dose. This suggests split high-dose oral LT4 as a therapeutic option in myxedema coma.
Keywords: Coma; hypothyroidism; myxedema; oral administration; thyroxine.
Figures
References
-
- Rodriguez, I. , Fluiters E., Perez‐Mendez L. F., Luna R., Paramo C., and Garcia‐Mayor R. V.. 2004. Factors associated with mortality of patients with myxoedema coma: prospective study in 11 cases treated in a single institution. J. Endocrinol. 180:347–350. - PubMed
-
- Wartofsky, L. . 2006. Myxedema coma. Endocrinol. Metab. Clin. North Am. 35:687–698, vii–viii. - PubMed
-
- Yamamoto, T. , Fukuyama J., and Fujiyoshi A.. 1999. Factors associated with mortality of myxedema coma: report of eight cases and literature survey. Thyroid 9:1167–1174. - PubMed
-
- Wall, C. R. 2000. Myxedema coma: diagnosis and treatment. Am. Fam. Physician 62:2485–2490. - PubMed
-
- Reinhardt, W. , and Mann K.. 1997. [Incidence, clinical picture and treatment of hypothyroid coma. Results of a survey]. Med. Klin. (Munich) 92:521–524. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
